Anaphylaxis

Yıl 2017, Cilt: 9 Sayı: 1, 19 - 23, 25.01.2017

Uzm. Dr. Gizem Atakul

Öz

Abstract

Anaphylaxis is a clinical emergency that is characterized by rapidly onset, life-threatening with airway, breathing and circulatory problems. Foods and drugs arethe most common causes in patients with anaphylaxis presenting to emergency department. In this review, diagnosis and treatment of anaphylaxis are summarized according to current literature.

Anahtar Kelimeler

naphylaxis, child, adolescents, treatment

Anafilaksi

Öz

Öz

Anafilaksi, hızlı başlangıçlı, yaşamı tehdit eden havayolu, solunum ve dolaşım problemleri ile karakterize klinik bir acildir. Gıdalar ve ilaçlar acil servise anafilaksi ilebaşvuran hastalarda en sık etkenlerdir. Anafilaksi düşünülen tüm hastalara intramüsküler olarak adrenalin uygulanmalıdır. Bu derlemede anafilaksinin tanı ve tedavisi güncel literatüre göre özetlenmiştir.

Anahtar Kelimeler

Anafilaksi, çocuk, adolesan, tedavi

Kaynakça

• Kaynaklar 1.Muraro A, Roberts G, Worm M, et al., on behalf of the EAA-CI Food Allergy and Anaphylaxis Guidelines Group. Anaphy-laxis: guidelines from the European Academy of Allergy andClinical Immunology. Allergy 2014; 69: 1026–45. 2.Johansson SG, Bieber T, Dahl R, et al. Revised nomenclatu-re for allergy for global use: report of the Nomenclature Re-view Committee of the World Allergy Organization, October2003. J Allergy Clin Immunol 2004; 113: 832-36. 3.Panesar SS, Javad S, De Silva D, et al. The epidemiology ofanaphylaxis in Europe: a systematic review. Allergy 2013; 68:1353–61. 4.Sampson HA. Fatal food-induced anaphylaxis. Allergy 1998:53: 125–30. 5.Cochran ST. Anaphylactoid reactions to radiocontrast media.Curr Allergy Asthma Rep 2005; 5 (1): 28-31. 6.Dykewicz MS. Positive autologous serum intradermal tests inidiopathic anaphylaxis. J Allergy Clin Immunol 1999; 103(Suppl): 53. 7.Grammer LC, Shaughnessy MA, Harris KE, Goolsby CL.Lymphocyte subsets and activation markers in patients with acute episodes of idiopathic anaphylaxis. Ann Allergy Asth-ma Immunol 2000; 85: 368-71. 8.Lieberman P. Anaphylaxis and anaphylactoid reactions. In:Middleton E, Reed CE, Reed CE, Ellis ET, et al. eds. AllergyPrinciples and Practice. Philadelphia: Mosby Co, 1998: 1079. 9.Sampson HA, Munoz-Furlong A, Campbell RL, et al. Secondsymposium on the definition and management of anaphylaxis:summary report – Second National Institute of Allergy and In-fectious Disease/Food Allergy and Anaphylaxis NetworkSymposium. J Allergy Clin Immunol 2006; 117: 391–97. 10.Sampson HA, Munoz-Furlong A, Bock SA, et al. Symposiumon the definition and management of anaphylaxis: summaryreport. J Allergy Clin Immunol 2005; 115: 584–91. 11.Harduar-Morano L, Simon MR, Watkins S, Blackmore C. Al-gorithm for the diagnosis of anaphylaxis and its validation usingpopulation-based data on emergency department visits foranaphylaxis in Florida. J Allergy Clin Immunol 2010; 126:98–104. 12.Campbell RL, Hagan JB, Manivannan V, et al. Evaluation ofnational institute of allergy and infectious diseases/food al-lergy and anaphylaxis network criteria for the diagnosis ofanaphylaxis in emergency department patients. J Allergy ClinImmunol 2012; 129: 748–52. 13.Worm M, Edenharter G, Rueff F, et al. Symptom profile andrisk factors of anaphylaxis in Central Europe. Allergy 2012;67: 691–98. 14.Simons FER, Ardusso LR, Bilo MB, et al. 2012 Update: WorldAllergy Organization Guidelines for the assessment and ma-nagement of anaphylaxis. Curr Opin Allergy Clin Immunol2012; 12: 389–99. 15.Steele R, Camacho-Halili M, Rosenthal B, Davis-Lorton M,Aquino M, Fonacier L. Anaphylaxis in the community setting:determining risk factors for admission. Ann Allergy AsthmaImmunol 2012; 109: 133–36. 16.Hompes S, Kohli A, Nemat K, et al. Provoking allergens andtreatment of anaphylaxis in children and adolescents – datafrom the anaphylaxis registry of German-speaking countries.Pediatr Allergy Immunol 2011; 22: 568–74.17.Braganza SC, Acworth JP, McKinnon DRL, Peake JE,Brown AFT. Paediatric emergency department anaphylaxis:different patterns from adults. Arch Dis Child 2006; 91:159–63. 18.Vetander M, Helander D, Flodstrom C, et al. Anaphylaxis andreactions to foods in children– a population-based case studyof emergency department visits. Clin Exp Allergy 2012; 42:568–77. 19.Beyer K, Eckermann O, Hompes S, Grabenhenrich L, WormM. Anaphylaxis in an emergency setting – elicitors, therapyand incidence of severe allergic reactions. Allergy 2012; 67:1451–56. 20.Douglas DM, Sukenick E, Andrade WP, Brown JS. Biphasicsystemic anaphylaxis: an inpatient and outpatient study. J Al-lergy Clin Immunol 1994; 93: 977–85. 21.Ellis AK, Day JH. Incidence and characteristics of biphasicanaphylaxis: a prospective evaluation of 103 patients. Ann Al-lergy Asthma Immunol 2007; 98: 64–69. 22.Lee JM, Greenes DS. Biphasic anaphylactic reactions in pe-diatrics. Pediatrics 2000; 106: 762–66. 23.Simons FER, Gu X, Johnston LM, Simons KJ. Can epineph-rine inhalations be substituted for epinephrine injection in child-ren at risk for systemic anaphylaxis? J Allergy Clin Immunol2000; 106: 1040–44. 24.Perel P, Roberts I. Colloids versus crystalloids for fluid re-suscitation in critically ill patients. Cochrane Database SystRev 2012; 6: CD000567. 25.Pumphrey RSH. Lessons for management of anaphylaxis froma study of fatal reactions. Clin Exp Allergy 2000; 30:1144–50. 26.Nurmatov UB, Rhatigan E, Simons FER, Sheikh A. H2 anti-histamines for the treatment of anaphylaxis with and witho-ut shock: a systematic review. Ann Allergy Asthma Immunol2014; 112: 126–31. 27.Thomas M. Best evidence topic report. Glucagon infusion inrefractory anaphylactic shock in patients on beta-blockers.Emerg Med J 2005; 22: 272–73.